Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension reference listed drug (RLD)

Method for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension reference listed drug (RLD)

US Patent 9989519 · Granted Jun 5, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

DNA antibody constructs for use against Pseudomonas aeruginosa2025
Device to facilitate safe transport of medical radioisotope systems2025
Radiopharmaceutical delivery system for patient infusion2025
Imaging method for diagnosing cardiovascular disease2025
Marburgvirus consensus antigens, nucleic acid constructs and vaccines made there2025
Filovirus consensus antigens, nucleic acid constructs and vaccines made therefro2025
Radiopharmaceutical delivery system and use thereof for patient infusion2025
DNA-encoded monoclonal antibodies targeting the Ebolavirus glycoprotein2024
Nucleic acid monoclonal antibodies targeting PCSK9 and methods of use2024
Radiopharmaceutical delivery system and use thereof for patient infusion2024
DNA monoclonal antibodies targeting influenza virus2023
Vaccines against coronavirus and methods of use2023